Effects of a Parent-Administered Exercise Program in the Neonatal Intensive Care Unit: Dose Does Matter-A Randomized

Gunn Kristin Øberg1, Gay L Girolami2, Suzann K Campbell3

  • 1Department of Health and Care Sciences, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, PB 6050 Langnes, Tromsø, 9037 Norway; and Department of Clinical Therapeutic Services, University Hospital North Norway, Tromsø, Norway.

Physical Therapy
|January 17, 2020
PubMed

Insights

A parent-administered exercise program in the neonatal intensive care unit (NICU) did not significantly improve motor skills in preterm infants. However, higher intervention doses correlated with better motor outcomes at three months corrected age.

Area of Science:

  • Neonatal care
  • Developmental pediatrics
  • Rehabilitation medicine

Background:

  • Preterm infants face risks of delayed motor development.
  • Interventions within the neonatal intensive care unit (NICU) and their dosing effects require further investigation.

Purpose of the Study:

  • To assess a parent-administered exercise program's effectiveness on preterm infants' motor outcomes at 3 months corrected age (CA).
  • To determine the impact of intervention dosage on motor performance in this population.

Main Methods:

  • A randomized clinical trial involving 153 infants born before 32 weeks gestational age.
  • A 3-week, twice-daily, 10-minute parent-administered exercise program in the NICU.
  • Motor outcome assessed using the Test of Infant Motor Performance (TIMP) at 3 months CA.

Main Results:

  • No significant difference in TIMP z-scores between intervention and control groups at 3 months CA.
  • A significant positive association between total intervention dose and TIMP z-scores.
  • Infants receiving less than the median intervention time had approximately 6 times higher odds of a clinical z-score < 0.

Conclusions:

  • The parent-administered exercise program showed no overall difference in motor performance at 3 months CA.
  • Increased intervention dosage was positively linked to improved motor outcomes.
  • Further research is needed, considering limitations such as small sample size for extremely preterm infants and potential spillover effects.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
198
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
207
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
165
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.8K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
168